HAGGERTY, TIMOTHY, J.,KURNICK, JAMES, T.,DUNN, IAN, S.
申请号：
EP12792958
公开号：
EP2714081A4
申请日:
2012.05.25
申请国别(地区):
EP
年份:
2015
代理人:
摘要：
The invention features methods, compositions, and kits for the administration of an HSP90 inhibitor, OBAA, flunarizine, aphidicolin, damnacanthal, dantrolene, or an analog thereof, alone, or in combination with, e.g., a TAA, an antigen-binding scaffold (e.g., an antibody, a soluble T cell receptor, or a chimeric receptor) specific for a TAA, a cell (e.g., a white blood cell that targets a cancer cell), and/or an IFN-&bgr； receptor agonist or an IFN-&gamma； receptor agonist, for the treatment of cancer.
